Search for: "Teva USA"
Results 541 - 560
of 714
Sorted by Relevance
|
Sort by Date
21 Jan 2015, 2:46 am
The other opinion came in Teva Pharmaceuticals USA v. [read post]
27 Jun 2013, 10:59 am
Tangerine FP Investments Ltd., 2012 BCCA 521 Teva Canada Ltd. v. [read post]
21 Jun 2022, 12:18 am
USA, Inc. v. [read post]
28 Dec 2010, 10:58 am
USA, Inc. v. [read post]
23 Aug 2011, 6:39 am
Teva Pharms. [read post]
2 Nov 2011, 2:00 am
Teva Pharmaceuticals USA et al (Docket Report) US: Fred Hutchinson Cancer Research Center files patent infringement complaint against Branhaven over sales of Canine Heritage XL Breed Test (Patent Docs) Products Atelvia (Risedronate sodium delayed-release) – US: Warner Chilcott files patent infringement complaint against Watson in response to Para IV certification (Patent Docs) Butrans (Buprenorphine) – US: PTO says PTE not available in “reverse… [read post]
24 Jul 2009, 1:49 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense. [read post]
13 Jun 2014, 6:00 am
USA, Inc. v. [read post]
26 Nov 2012, 10:19 pm
Circuit’s March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
6 Apr 2011, 12:18 am
Laboratorios Rubió (EPLAW) Gemzar (Gemcitabine) – US: ITC: Target date of 23 July 2012 set in Certain Gemcitabine (ITC 337 Law Blog) Intuniv (Guanfacine) – US: Shire files patent infringement complaint based on Mylan’s ANDA filing (Patent Docs) Isentress (Raltegravir) – India: Cipla files for compulsory license against Merck’s Isentress (Spicy IP) Losartan, HCTZ – France: Cour d’appel confirms combination products infringe mono-SPCs and sets… [read post]
2 Sep 2010, 10:51 am
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
8 May 2020, 6:57 pm
Teva Pharm. [read post]
14 Nov 2022, 2:55 am
It should be noted, in this regard, that this puts the European Union in a different situation from that of the UK, where the same disclosure obligations apparently do not exist and which could therefore become a more interesting territory for clinical trials, and even the USA, where the disclosure obligation is triggered only after the so-called phase 1 of clinical trials has been carried out. [read post]
30 May 2019, 2:02 pm
Teva Pharm. [read post]
13 Aug 2019, 7:34 pm
Teva Pharm. [read post]
1 Apr 2020, 3:36 pm
Teva Pharm. [read post]
5 Nov 2012, 11:17 am
Teva Pharmas., USA, Inc., 2012 WL 5364392 (M.D. [read post]
15 Jun 2015, 7:13 am
******************PREVIOUSLY, ON NEVER TOO LATE Never too late 49 [week ending on Sunday 31 May] - Another copyright-exhaustion-and-software reference to the CJEU | ORO trade marks and GC | Patent Reform in EU | Copyright in the Bahamas | More and more references to the CJEU: communication to the public and linking | Trade secrets and the FoMo phenomenon | Independence of EPO’s BoA.Never too late 48 [week ending on Sunday 31 May] - The… [read post]
30 Oct 2019, 6:31 pm
Teva Pharms. [read post]
30 Jan 2015, 1:48 pm
Teva Pharms., USA, Inc., No. [read post]
